Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 8325915, 12 pages
https://doi.org/10.1155/2018/8325915
Research Article

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR−/− Mouse Strain

1Department of Medical Microbiology and Immunobiology, University of Szeged, Dóm Tér 10, Szeged 6720, Hungary
2Institute of Surgical Research, University of Szeged, Szőkefalvi-Nagy Béla U. 6, Szeged 6720, Hungary
3The Mary and Garry Weston Molecular Immunology Laboratory, Thrombosis Research Institute, Emmanuel Kaye Building, Manresa Road, London SW3 6LR, UK

Correspondence should be addressed to Valéria Endrész; uh.degezs-u.dem@airelav.zserdne

Received 14 November 2017; Revised 31 January 2018; Accepted 18 February 2018; Published 25 March 2018

Academic Editor: Daniele Corsaro

Copyright © 2018 Ildikó Lantos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Weber and H. Noels, “Atherosclerosis: current pathogenesis and therapeutic options,” Nature Medicine, vol. 17, no. 11, pp. 1410–1422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Lloyd-Jones, R. Adams, M. Carnethon et al., “Heart disease and stroke statistics—2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee,” Circulation, vol. 119, no. 3, pp. 480–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Knopp and P. Paramsothy, “Treatment of hypercholesterolemia in patients with metabolic syndrome: How do different statins compare?” Nature Clinical Practice Endocrinology & Metabolism, vol. 2, no. 3, pp. 136-137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. F. Bentzon, F. Otsuka, R. Virmani, and E. Falk, “Mechanisms of plaque formation and rupture,” Circulation Research, vol. 114, no. 12, pp. 1852–1866, 2014. View at Publisher · View at Google Scholar
  5. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group, “Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 13, no. 9, pp. 1291–1298, 1993. View at Google Scholar
  6. P. Libby, P. M. Ridker, and G. K. Hansson, “Inflammation in atherosclerosis: from pathophysiology to practice,” Journal of the American College of Cardiology, vol. 54, no. 23, pp. 2129–2138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Lusis, “Atherosclerosis,” Nature, vol. 407, no. 6801, pp. 233–241, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Aikawa, E. Rabkin, S. J. Voglic et al., “Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma,” Circulation Research, vol. 83, no. 10, pp. 1015–1026, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Muhlestein, B. D. Horne, J. F. Carlquist et al., “Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease,” Circulation, vol. 102, no. 16, pp. 1917–1923, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kurita-Ochiai, R. Jia, Y. Cai, Y. Yamaguchi, and M. Yamamoto, “Periodontal disease-induced atherosclerosis and oxidative stress,” Antioxid Basel Switz, vol. 4, no. 3, pp. 577–590, 2015. View at Publisher · View at Google Scholar
  11. M. E. Cabalén, M. F. Cabral, L. M. Sanmarco et al., “Chronic Trypanosoma cruzi infection potentiates adipose tissue macrophage polarization toward an anti-inflammatory M2 phenotype and contributes to diabetes progression in a diet-induced obesity model,” Oncotarget , vol. 7, no. 12, pp. 13400–13415, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. L. A. Campbell and M. E. Rosenfeld, “Infection and Atherosclerosis Development,” Archives of Medical Research, vol. 46, no. 5, pp. 339–350, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Watson and N. Alp, “Role of Chlamydia pneumoniae in atherosclerosis,” Clinical Science, vol. 114, no. 8, pp. 509–531, 2008. View at Publisher · View at Google Scholar
  14. G. Fazio, M. Giovino, A. Gullotti, D. Bacarella, G. Novo, and S. Novo, “Atherosclerosis, inflammation and Chlamydia pneumoniae,” World Journal of Cardiology, vol. 1, no. 1, pp. 31–40, 2009. View at Google Scholar
  15. F. Blasi, P. Tarsia, and S. Aliberti, “Chlamydophila pneumoniae,” Clinical Microbiology and Infection, vol. 15, no. 1, pp. 29–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. W. L. Beatty, R. P. Morrison, and G. I. Byrne, “Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis,” Microbiology and Molecular Biology Reviews, vol. 58, no. 4, pp. 686–699, 1994. View at Google Scholar · View at Scopus
  17. R. Tewari, V. S. Nijhawan, M. N. Mishra, P. Dudeja, and T. K. Salopal, “Prevalence of helicobacter pylori, cytomegalovirus, and chlamydia pneumonia immunoglobulin seropositivity in coronary artery disease patients and normal individuals in north indian population,” Medical Journal Armed Forces India, vol. 68, no. 1, pp. 53–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Burian, Z. Kis, D. Virok et al., “Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis,” Circulation, vol. 103, no. 11, pp. 1503–1508, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Jawien, P. Nastalek, R. Korbut, J. Jawień, and P. Nastałek, “Mouse models of experimental atherosclerosis,” Journal of Physiology and Pharmacology, vol. 55, no. 3, pp. 503–517, 2004. View at Google Scholar
  20. F. R. Kapourchali, G. Surendiran, L. Chen, E. Uitz, B. Bahadori, and M. H. Moghadasian, “Animal models of atherosclerosis,” World Journal of Clinical Cases, vol. 2, no. 5, pp. 126–132, 2014. View at Publisher · View at Google Scholar
  21. L. Powell-Braxton, M. Véniant, R. D. Latvala et al., “A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet,” Nature Medicine, vol. 4, no. 8, pp. 934–938, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Plump, J. D. Smith, T. Hayek et al., “Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells,” Cell, vol. 71, no. 2, pp. 343–353, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Rader and G. A. FitzGerald, “State of the art: Atherosclerosis in a limited edition,” Nature Medicine, vol. 4, no. 8, pp. 899-900, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. P. Yang, C. C. Kuo, and J. Thomas Grayston, “Systemic dissemination of chlamydia pneumoniae following intranasal inoculation in mice,” The Journal of Infectious Diseases, vol. 171, no. 3, pp. 736–738, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Kis, K. Burian, B. Treso et al., “Inflammatory- and immune responses in relation to bacterial replication in mice following re-infections with Chlamydophila pneumoniae,” Inflammation Research, vol. 57, no. 6, pp. 287–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Chen, K. Shimada, W. Zhang, G. Huang, T. R. Crother, and M. Arditi, “IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice,” The Journal of Immunology, vol. 185, no. 9, pp. 5619–5627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Liu, H. Hu, H. Ji, A. D. Murdin, G. N. Pierce, and G. Zhong, “Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/-mouse model within six months,” Molecular and Cellular Biochemistry, vol. 215, no. 1-2, pp. 123–128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Blessing, L. A. Campbell, M. E. Rosenfeld, B. Chesebro, and C.-C. Kuo, “A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae,” Journal of Antimicrobial Chemotherapy, vol. 55, no. 6, pp. 1037–1040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Burián, H. Hegyesi, E. Buzás et al., “Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung,” Immunology Letters, vol. 89, no. 2-3, pp. 229–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Bogdanov, V. Endrész, S. Urbán et al., “Application of dna chip scanning technology for automatic detection of chlamydia trachomatis and chlamydia pneumoniae inclusions,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 1, pp. 405–413, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. R. V. Farese Jr., M. M. Véniant, C. M. Cham et al., “Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 93, no. 13, pp. 6393–6398, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. D. M. Wuttge, A. Sirsjö, P. Eriksson, and S. Stemme, “Gene expression in atherosclerotic lesion of ApoE deficient mice,” Molecular Medicine, vol. 7, no. 6, pp. 383–392, 2001. View at Google Scholar · View at Scopus
  33. N. M. Rothstein, T. C. Quinn, G. Madico, C. A. Gaydos, and C. J. Lowenstein, “Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumomiae,” The Journal of Infectious Diseases, vol. 183, no. 2, pp. 232–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Erkkilä, K. Laitinen, K. Haasio et al., “Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection,” Atherosclerosis, vol. 177, no. 2, pp. 321–328, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Paigen, A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams, “Quantitative assessment of atherosclerotic lesions in mice,” Atherosclerosis, vol. 68, no. 3, pp. 231–240, 1987. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Mannonen, E. Kamping, T. Penttilä, and M. Puolakkainen, “IFN-γ induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture,” Microbial Pathogenesis, vol. 36, no. 1, pp. 41–50, 2004. View at Publisher · View at Google Scholar
  37. T. Mosolygó, J. Korcsik, E. P. Balogh et al., “Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation,” Inflammation Research, vol. 62, no. 5, pp. 451–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Dhanasekaran, T. M. Doherty, and J. Kenneth, “Comparison of different standards for real-time PCR-based absolute quantification,” Journal of Immunological Methods, vol. 354, no. 1-2, pp. 34–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Sorrentino, A. Yilmaz, K. Schubert et al., “A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice,” Cellular Immunology, vol. 294, no. 1, pp. 25–32, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. S. B. Damy, M. L. Higuchi, J. Timenetsky et al., “Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice,” BMC Microbiology, vol. 9, article no. 194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Nazzal, N. Therville, H. Yacoub-Youssef et al., “Apolipoprotein e-deficient mice develop an anti-chlamydophila pneumoniae T helper 2 response and resist vascular infection,” The Journal of Infectious Diseases, vol. 202, no. 5, pp. 782–790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. C. Moazed, C.-C. Kuo, J. T. Grayston, and L. A. Campbell, “Murine models of Chlamydia pneumoniae infection and atherosclerosis,” The Journal of Infectious Diseases, vol. 175, no. 4, pp. 883–890, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Hu, G. N. Pierce, and G. Zhong, “The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae,” The Journal of Clinical Investigation, vol. 103, no. 5, pp. 747–753, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. T. C. Moazed, L. A. Campbell, M. E. Rosenfeld, J. T. Grayston, and C.-C. Kuo, “Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice,” The Journal of Infectious Diseases, vol. 180, no. 1, pp. 238–241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Blessing, L. A. Campbell, M. E. Rosenfeld, N. Chough, and C.-C. Kuo, “Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice,” Atherosclerosis, vol. 158, no. 1, pp. 13–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Naiki, R. Sorrentino, M. H. Wong et al., “TLR/MyD88 and liver X receptor α signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis,” The Journal of Immunology, vol. 181, no. 10, pp. 7176–7185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. L. A. Campbell, T. C. Moazed, C.-C. Kuo, and J. T. Grayston, “Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice,” Clinical Microbiology and Infection, vol. 4, Suppl 4, pp. S23–S32, 1998. View at Publisher · View at Google Scholar
  48. L. A. Campbell and M. E. Rosenfeld, “Persistent C. pneumoniae infection in atherosclerotic lesions: Rethinking the clinical trials,” Frontiers in Cellular and Infection Microbiology, vol. 5, Article ID Article 34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Hyvärinen, A. M. Tuomainen, S. Laitinen et al., “The effect of proatherogenic pathogens on adipose tissue transcriptome and fatty acid distribution in apolipoprotein E-deficient mice,” BMC Genomics, vol. 14, no. 1, article no. 709, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Marangoni, E. Fiorino, F. Gilardi et al., “Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice,” Atherosclerosis, vol. 241, no. 2, pp. 471–479, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Tuomainen, K. Hyvärinen, P. I. Ehlers et al., “The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice,” Microbial Pathogenesis, vol. 51, no. 3, pp. 217–224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Van Oosten, P. C. N. Rensen, E. S. Van Amersfoort et al., “Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality: A new therapeutic approach to treat Gram-negative sepsis,” The Journal of Biological Chemistry, vol. 276, no. 12, pp. 8820–8824, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. W. Khovidhunkit, M.-S. Kim, R. A. Memon et al., “Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host,” Journal of Lipid Research, vol. 45, no. 7, pp. 1169–1196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. K. R. Feingold, I. Hardardottir, R. Memon et al., “Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters,” Journal of Lipid Research, vol. 34, no. 12, pp. 2147–2158, 1993. View at Google Scholar · View at Scopus
  55. K. Kontula, A. Vuorio, H. Turtola, and P. Saikku, “Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia,” The Lancet, vol. 354, no. 9172, pp. 46-47, 1999. View at Publisher · View at Google Scholar · View at Scopus